These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 901462)

  • 1. Verification of both the sequence and conformational specificity of neurotensin in binding to mast cells.
    Lazarus LH; Perrin MH; Brown MR; Rivier JE
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1079-85. PubMed ID: 901462
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible conformations involved in the binding of neurotensin, xenopsin and bradykinin molecules to mast cell receptors.
    Podinsh LU; Betinsh YaR ; Nikiforovich GV; Chipens GI
    FEBS Lett; 1983 Mar; 153(1):25-8. PubMed ID: 6825862
    [No Abstract]   [Full Text] [Related]  

  • 3. Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding to mast cell receptor sites.
    Lazarus LH; Perrin MH; Brown MR; Rivier JE
    J Biol Chem; 1977 Oct; 252(20):7180-3. PubMed ID: 198404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of an adriamycin-binding site on mast cell surface during exocytosis.
    Bartoli Klugmann F; Decorti G; Candussio L; Crivellato E; Mallardi F; Baldini L
    Pharmacol Res; 1990; 22 Suppl 3():89-90. PubMed ID: 2097663
    [No Abstract]   [Full Text] [Related]  

  • 5. Conformational changes and drug action.
    Burgen AS
    Fed Proc; 1981 Nov; 40(13):2723-8. PubMed ID: 7297703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for bradykinin in intestinal and uterine smooth muscle.
    Brabé J; Drouin JN; Regoli D; Park WK
    Can J Physiol Pharmacol; 1977 Dec; 55(6):1270-85. PubMed ID: 597778
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides.
    Burt DS; Stanworth DR
    Eur J Immunol; 1987 Mar; 17(3):437-40. PubMed ID: 2952512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of a cobra neurotoxin and affinity labels of the acetylcholine receptor in the electroplax.
    Prives JM; Reiter MJ; Cowburn DA; Karlin A
    Mol Pharmacol; 1972 Nov; 8(6):786-9. PubMed ID: 4641006
    [No Abstract]   [Full Text] [Related]  

  • 9. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition for diazepam receptor binding by diphenylhydantoin and its enhancement by gamma-aminobutyric acid.
    Tunnicliff G; Smith JA; Ngo TT
    Biochem Biophys Res Commun; 1979 Dec; 91(3):1018-24. PubMed ID: 526263
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology and biochemistry of neurotensin receptors.
    Kitabgi P; Checler F; Mazella J; Vincent JP
    Rev Clin Basic Pharm; 1985; 5(3-4):397-486. PubMed ID: 2881326
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells.
    Braga T; Ringvall M; Tveit H; Abrink M; Pejler G
    Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SH-modifying reagents on the rat hepatic Ah receptor: inhibition of ligand binding and transformation, and disruption of the ligand-receptor complex.
    Henry EC; Kester JE; Gasiewicz TA
    Biochim Biophys Acta; 1988 Mar; 964(3):361-76. PubMed ID: 2831991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an endogenous peptide-ligand for the benzodiazepine receptor.
    Davis LG; Cohen RK
    Biochem Biophys Res Commun; 1980 Jan; 92(1):141-8. PubMed ID: 7356447
    [No Abstract]   [Full Text] [Related]  

  • 15. beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity.
    Skolnick P; Williams EF; Cook JM; Cain M; Rice KC; Mendelson WB; Crawley JN; Paul SM
    Prog Clin Biol Res; 1982; 90():233-52. PubMed ID: 6287491
    [No Abstract]   [Full Text] [Related]  

  • 16. High affinity inhibition of [3H]-flunitrazepam binding to brain benzodiazepine receptors by CGS 9896, a novel pyrazoloquinoline.
    Gee KW; Horst WD; O'Brien R; Yamamura HI
    Biochem Biophys Res Commun; 1982 Mar; 105(2):457-61. PubMed ID: 6124246
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.
    Aswanikumar S; Corcoran B; Schiffmann E; Day AR; Freer RJ; Showell HJ; Becker EL
    Biochem Biophys Res Commun; 1977 Jan; 74(2):810-7. PubMed ID: 836328
    [No Abstract]   [Full Text] [Related]  

  • 18. Exocytosis and membrane recycling in adriamycin-treated rat peritoneal mast cells.
    Decorti G; Bartoli Klugmann F; Crivellato E; Candussio L; Mallardi F; Baldini L
    Acta Physiol Hung; 1990; 75 Suppl():79-80. PubMed ID: 1695421
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin.
    Foreman JC; Jordan CC; Piotrowski W
    Br J Pharmacol; 1982 Nov; 77(3):531-9. PubMed ID: 6182939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of adriamycin uptake and internalization by receptor-mediated endocytosis in mast cells. An ultrastructural study using adriamycin-colloidal gold complexes.
    Crivellato E; Mallardi F; Bartoli Klugmann F; Decorti G; Candussio L; Baldini L
    Pharmacol Res; 1989; 21 Suppl 1():125-6. PubMed ID: 2633161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.